Accessibility Tools

Coronavirus (COVID-19)

For health information and advice, read our pages on coronavirus. Learn about the government response to coronavirus on GOV.UK.

Notice of CCG closure

From 1 July 2022 please visit our new ICB website https://staffsstoke.icb.nhs.uk/

On 1 July 2022, the six Clinical Commissioning Groups (CCGs) in Staffordshire and Stoke-on-Trent closed down and the functions of the CCGs transferred to a new NHS organisation, known as an integrated care board. The new organisation is responsible for NHS spend and the day-to-day running of the NHS in Staffordshire and Stoke-on-Trent.

Therefore, South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group no longer exists and the responsibilities of the CCG, along with the other CCGs in Staffordshire and Stoke-on-Trent, have transferred to the new NHS Staffordshire and Stoke-on-Trent Integrated Care Board (ICB).

These changes have taken place under the new Health and Care Act 2022, which amongst other things aims to tackle health inequalities and create safer, more joined-up services that will put the health and care system on a more sustainable footing. There are no changes to how local residents access NHS frontline services in Staffordshire and Stoke-on-Trent as part of these changes.

From 1 July 2022 if you visit this website, you will be re-directed to the new ICB website.

Preferred Pescribing List for South Staffordshire CCGs, Burton Hospital NHS Foundation Trust & Mid Staffordshire Hospitals Foundation Trust

on .

How to use

  • The preferred prescribing list for the various therapeutic sections of the British National Formulary (BNF) can be accessed via the links shown in the menu bar on the left hand side of this screen
  • Links are identified throughout by underlined text (e.g. link)
  • Drugs are colour coded according to the following criteria:

Prescribing criteria

GREEN

Suitable first-line drugs for implementation in primary care

 

AMBER

 

Second-line drugs. Either more clinically or cost-effective drugs are available or use should be restricted to certain groups (including ESCAs) or specialist initiation groups. They may be prescribed within primary and secondary care.

RED

Drugs which require special consideration. These are drugs for consultant prescribing only. They should not be prescribed in Primary Care.

Each section contains prescribing notes with links to specific management guidelines in many cases.

Other links to locally approved prescribing protocols (e.g. shared care agreements) are also included.